Search Results for "Treatment Of Neurofibroma In India"

22:34 EST 1st March 2015 | BioPortfolio

Matching Channels

India

India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...

India ink colloidal carbon stain

Pediculosis - louse (lice) treatment

   To view our most recent articles on Lice Treatment please go to: http://www.bioportfolio.com/news/article/987636/Pediculosis-Louse-Lice-Treatment.html    

Specific treatment

Treatment of Anemia

Matching News

Rheumatology in India—quo vadis?

The treatment of rheumatic diseases in India is beset with several problems, such as a high patient load and grossly inadequate number of trained rheumatology specialists. In this Perspectives article...

'Cancer care in India needs urgent attention'

Biospectrum A Cancer conclave was held at Aster Medcity, Kochi, India to analyze the demographics of cancer care in Ind...

Which doctors have been shortlisted for the BMJ Awards India 2014?

We received more than 500 high quality nominations for the first BMJ Awards India, showing medical excellence in diverse work throughout India.1 2 The BMJ team in India had the unenviable task of... ...

‘India Ranks among Top 3 Medical Tourism Destinations in Asia’

(The Economic Times) – India is placed among the top three medical tourism destinations in Asia, mainly due to the low cost of treatment, quality healthcare infrastructure and availability of hi...

Judging the best of Indian healthcare

“We received an overwhelming number of nominations,” said Anand Ekambaram, managing director of BMJ India. More than 500 individuals and teams throughout India have been put forward.1“The BMJ In...

Mylan and Gilead partner for Sovaldi and Harvoni in India

Mylan has been appointed as the exclusive distributor of Sovaldi (sofosbuvir 400mg tablets) and Harvoni (ledipasvir 90mg/sofosbuvir 400 mg tablets) for the treatment of chronic hepatitis C, in India. ...

India suffers HIV drug shortages

Supply bottlenecks and late payments to drugmakers have hit HIV treatment supplies across India, according to reports in the Indian press. The drug shortages, which affect those least able to pay, hav...

PM Modi’s Japan Visit: India to Work with Japan in Finding Sickle Cell Anemia Remedy

(The Economic Times) – Japan today agreed to work with India in developing a treatment for the Sickle Cell Anaemia after Prime Minister Narendra Modi sought help for finding remedy to the deadly...

Matching PubMed Articles

Neurofibroma of the palate.

Neurofibroma is a benign peripheral nerve sheath tumor comprising variable mixture of Schwann cells, perineurial-like cells, and fibroblasts. Neurofibroma may occur as solitary lesion or as part of a ...

A Rare Solitary Neurofibroma of the Frontal Sinus.

Neurofibromas are common peripheral nerve sheath tumors related to Schwann cell's proliferation and are usually associated with neurofibromatosis type 1. Although solitary neurofibroma that occurs in ...

Extensive Plexiform Neurofibroma in a Premature Neonate.

We describe a premature neonate with an extensive plexiform neurofibroma. Prenatal ultrasound at 32 weeks of gestation was normal. Postnatal examination was significant for a palpable left neck mass. ...

Self-Administered Tuberculosis Treatment Outcomes in a Tribal Population on the Indo-Myanmar Border, Nagaland, India.

Multiple strategies are being adopted by national tuberculosis (TB) programmes to achieve universal coverage of tuberculosis treatment. However, populations living in 'hard-to-reach' areas of north-ea...

A multicentre retrospective study to understand anti-platelet treatment patterns and outcomes of acute coronary syndrome patients in India (TRACE).

There is limited available information for treatment of acute coronary syndrome (ACS) with respect to outcomes, therapeutic agents and treatment practices. Our retrospective registry study collected a...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement